Director Patrick G. Enright made bold open market purchases of biotech stocks over the last year, with no sales recorded. He bought Zenas BioPharma ($ZBIO) shares twice for $2.25 million, most recently on October 9, 2025, ranking 288th among nearly 5,000 insiders. In Veradermics ($MANE), he invested $18.3 million across two trades, latest on February 5, 2026, placing 65th. He added $5.5 million in Vera Therapeutics ($VERA) over five purchases, most recent December 11, 2025, at 156th. These outpace the average insider buy of $1.5 million across 3.3 trades.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 5, 2026 | Veradermics, Inc | $MANE | ENRIGHT PATRICK G | Director | C | Common Stock | 1236631 | $0.00 | 1,236,631.0000 | 0 | 9999.99% | 0.00% |
| Feb. 3, 2026 | Veradermics, Inc | $MANE | ENRIGHT PATRICK G | Director | A | Stock Option (Right to Buy) | 45131 | $0.00 | 45,131.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | ENRIGHT PATRICK G | Director | C | Series C Convertible Preferred Stock | 1171121 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | ENRIGHT PATRICK G | Director | C | Series C Convertible Preferred Stock | 1171121 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | ENRIGHT PATRICK G | Director | C | Series B Convertible Preferred Stock | 1236631 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | ENRIGHT PATRICK G | Director | P | Common Stock | 882353 | $17.00 | 2,053,474.0000 | 0 | 75.34% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | ENRIGHT PATRICK G | Director | P | Common Stock | 192647 | $17.00 | 2,600,399.0000 | 0 | 8.00% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | ENRIGHT PATRICK G | Director | C | Common Stock | 1171121 | $0.00 | 1,171,121.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2026 | Veradermics, Inc | $MANE | ENRIGHT PATRICK G | Director | C | Common Stock | 1171121 | $0.00 | 2,407,752.0000 | 0 | 94.70% | 0.00% |
| Aug. 18, 2025 | Jazz Pharmaceuticals plc | $JAZZ | ENRIGHT PATRICK G | Director | J | Ordinary Shares | 5000 | $0.00 | 21,379.0000 | 66,007,000 | 18.95% | 0.01% |
| Dec. 11, 2025 | Vera Therapeutics, Inc. | $VERA | ENRIGHT PATRICK G | Not found | P | Class A Common Stock | 5882 | $42.50 | 5,400,094.0000 | 63,928,066 | 0.11% | 0.01% |
| Oct. 9, 2025 | Zenas BioPharma, Inc. | $ZBIO | ENRIGHT PATRICK G | Not found | P | Common Stock | 11990 | $20.85 | 2,619,189.0000 | 42,159,340 | 0.46% | 0.03% |
| Oct. 9, 2025 | Zenas BioPharma, Inc. | $ZBIO | ENRIGHT PATRICK G | Not found | P | Common Stock | 105265 | $19.00 | 2,619,189.0000 | 42,159,340 | 4.19% | 0.25% |
| Aug. 7, 2025 | Jazz Pharmaceuticals plc | $JAZZ | ENRIGHT PATRICK G | Director | A | Ordinary Shares | 3507 | $0.00 | 28,184.0000 | 66,007,000 | 14.21% | 0.01% |
| Aug. 8, 2025 | Jazz Pharmaceuticals plc | $JAZZ | ENRIGHT PATRICK G | Director | F | Ordinary Shares | 1805 | $111.25 | 26,379.0000 | 66,007,000 | 6.40% | 0.00% |
| June 24, 2025 | Vera Therapeutics, Inc. | $VERA | ENRIGHT PATRICK G | Not found | P | Class A Common Stock | 13536 | $22.35 | 1,797,619.0000 | 63,748,290 | 0.76% | 0.02% |
| June 24, 2025 | Vera Therapeutics, Inc. | $VERA | ENRIGHT PATRICK G | Not found | P | Class A Common Stock | 27071 | $22.35 | 3,596,593.0000 | 63,748,290 | 0.76% | 0.04% |
| June 23, 2025 | Vera Therapeutics, Inc. | $VERA | ENRIGHT PATRICK G | Not found | P | Class A Common Stock | 139595 | $20.87 | 3,569,522.0000 | 63,748,290 | 4.07% | 0.22% |
| June 23, 2025 | Vera Therapeutics, Inc. | $VERA | ENRIGHT PATRICK G | Not found | P | Class A Common Stock | 69798 | $20.87 | 1,784,083.0000 | 63,748,290 | 4.07% | 0.11% |
| June 10, 2025 | Zenas BioPharma, Inc. | $ZBIO | ENRIGHT PATRICK G | Director | A | Stock Option (Right to Buy) | 18500 | $0.00 | 18,500.0000 | 41,800,802 | 9999.99% | 0.04% |
| June 5, 2025 | BioAge Labs, Inc. | $BIOA | ENRIGHT PATRICK G | Not found | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 35,850,037 | 9999.99% | 0.06% |
| May 14, 2025 | Vera Therapeutics, Inc. | $VERA | ENRIGHT PATRICK G | Not found | A | Stock Option (right to buy) | 14000 | $0.00 | 14,000.0000 | 63,748,290 | 9999.99% | 0.02% |
| Sept. 25, 2024 | BioAge Labs, Inc. | $BIOA | ENRIGHT PATRICK G | Not found | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 27, 2024 | BioAge Labs, Inc. | $BIOA | ENRIGHT PATRICK G | Not found | P | Common Stock | 400000 | $18.00 | 1,710,589.0000 | 0 | 30.52% | 0.00% |
| Sept. 27, 2024 | BioAge Labs, Inc. | $BIOA | ENRIGHT PATRICK G | Not found | C | Common Stock | 1310589 | $0.00 | 1,310,589.0000 | 0 | 9999.99% | 0.00% |
| Sept. 27, 2024 | BioAge Labs, Inc. | $BIOA | ENRIGHT PATRICK G | Not found | C | Series D Preferred Stock | 5848637 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | ENRIGHT PATRICK G | Director | P | Common Stock | 440000 | $17.00 | 774,530.0000 | 1,567,269 | 131.53% | 28.07% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | ENRIGHT PATRICK G | Director | C | Series B Convertible Preferred Stock | 6284933 | $0.00 | 0.0000 | 1,567,269 | 100.00% | 100.00% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | ENRIGHT PATRICK G | Director | C | Series C Convertible Preferred Stock | 8714293 | $0.00 | 0.0000 | 1,567,269 | 100.00% | 100.00% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | ENRIGHT PATRICK G | Director | C | Series C Convertible Preferred Stock | 2904764 | $0.00 | 0.0000 | 1,567,269 | 100.00% | 100.00% |
| Sept. 12, 2024 | Zenas BioPharma, Inc. | $ZBIO | ENRIGHT PATRICK G | Director | A | Stock Option (Right to Buy) | 37000 | $0.00 | 37,000.0000 | 1,567,269 | 9999.99% | 2.36% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | ENRIGHT PATRICK G | Director | C | Common Stock | 1003592 | $0.00 | 1,727,404.0000 | 1,567,269 | 138.65% | 64.03% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | ENRIGHT PATRICK G | Director | C | Common Stock | 723812 | $0.00 | 723,812.0000 | 1,567,269 | 9999.99% | 46.18% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | ENRIGHT PATRICK G | Director | C | Common Stock | 334530 | $0.00 | 334,530.0000 | 1,567,269 | 9999.99% | 21.35% |
| Aug. 2, 2024 | Jazz Pharmaceuticals plc | $JAZZ | ENRIGHT PATRICK G | Director | A | Ordinary Shares | 3731 | $0.00 | 24,677.0000 | 72,066,000 | 17.81% | 0.01% |
| May 15, 2024 | Vera Therapeutics, Inc. | $VERA | ENRIGHT PATRICK G | Not found | A | Stock Option (right to buy) | 14000 | $0.00 | 14,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 14, 2023 | Jazz Pharmaceuticals plc | $JAZZ | ENRIGHT PATRICK G | Director | S | Ordinary Shares | 1241 | $138.16 | 20,946.0000 | 62,539,000 | 5.59% | 0.00% |
| Aug. 11, 2023 | Jazz Pharmaceuticals plc | $JAZZ | ENRIGHT PATRICK G | Director | A | Ordinary Shares | 3075 | $0.00 | 22,187.0000 | 62,539,000 | 16.09% | 0.00% |
| May 10, 2023 | Vera Therapeutics, Inc. | $VERA | ENRIGHT PATRICK G | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2023 | Vera Therapeutics, Inc. | $VERA | ENRIGHT PATRICK G | Director | P | Class A Common Stock | 1714285 | $7.00 | 5,144,212.0000 | 0 | 49.98% | 0.00% |